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Abstract
Background: Small dense low-density lipoprotein (sdLDL), which 
has a small LDL particle size with a greater susceptibility to oxida-
tion, is considered a risk marker for cardiovascular disease (CVD). 
The diacron reactive oxygen metabolites (d-ROMs) have recently 
been introduced as a clinically useful oxidative stress-related marker. 
Physical activity can reduce the CVD risk. The present study inves-
tigated the correlation between the changes of the mean LDL par-
ticle size and the oxidative stress status, as assessed by the d-ROMs, 
in a physical activity intervention in hyperlipidemic subjects.
Methods: We performed a 6-month intervention study of 30 hy-
perlipidemic subjects (12 male/18 female, mean age 64 years), fo-
cusing on a moderate physical activity increase. The clinical data, 
including the atherosclerotic risk factors besides the mean LDL par-
ticle size measured with the gel electrophoresis and the d-ROMs, 
were evaluated pre- and post-intervention.
Results: The mean LDL particle size was significantly larger in the 
post-intervention than in the pre-intervention evaluation (26.9 ± 0.3 
(SD) vs. 27.1 ± 0.4 nm, P < 0.01), while the d-ROMs levels were 
significantly reduced in the post-intervention period compared to 
those at pre-intervention (319 ± 77 vs. 290 ± 73 U. Carr., P < 0.05). 
A stepwise multiple regression analysis revealed that there was an 
independent, significant and inverse correlation between the pre- 
and post-intervention changes of the d-ROMs and the mean LDL 
particle size (β = -0.55, P < 0.01).
Conclusions: The intervention study suggests that sdLDL and oxi-
dative stress can concomitantly affect the risk of developing CVD 
and that both factors can improve by even a moderate increase in 
physical activity among hyperlipidemic subjects.
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Introduction
Cardiovascular disease (CVD) remains a major sociomedi-
cal burden, and the regulation of incident CVD is a public-
health challenge [1]. CVD is a multi-factorial disorder, and 
hyperlipidemia is also associated with the development of 
CVD [1]. In addition to the classic atherosclerotic risk fac-
tors, lipoprotein disorders, including the existence of small 
dense  low-density  lipoprotein  (sdLDL),  and  the  presence 
of oxidative stress are considered to be the risk factors, and 
have  attracted  increasing  attention  in  recent  years  [2-7]. 
Regular physical activity can reduce the CVD risk, although 
the biological mechanisms underlying this reduction remain 
incompletely elucidated [8-10].
Small dense LDL particles (showing a smaller LDL par-
ticle size) are highly susceptible to oxidation, and their oxida-
tion concept is related to the atherogenic potential of sdLDL 
particles and is associated with incident CVD [2, 3, 5, 6]. In 
general, regular physical activity improves lipoprotein/lipid 
disorders in adults [11]. Persistent intervention studies spe-
cific for regular exercise have reported a significant reduc-
tion of sdLDL levels (that is, indicating a change toward a 
larger LDL particle size) [12, 13], although a cross-sectional 
study has conflictingly reported a non-significant difference 
in sdLDL levels between habitual exercisers and sedentary 
male subjects [14]. However, because there are complex in-
terdependencies between many atherosclerotic risk factors, 
whether the influence of sdLDL on the development of CVD 
is independent of other atherosclerotic risk factors is still be-
ing debated [6].
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Oxidative stress is present when an oxidative environ-
ment develops due to an imbalance between oxidative re-
actants, such as reactive oxygen species (ROS), and anti-
oxidants [15-17]. While oxidative stress is considered to be 
involved in the development of CVD [4, 7], several stud-
ies specific for exercise have reported that regular exercise 
results in a reduction of malondialdehyde and/or lipid per-
oxidation  products  as  oxidative  stress-related  markers  in 
diseased patients [18-21]. However, studies using oxidative 
stress have had limited indices available to easily analyze the 
oxidative stress status of patients in the clinical setting [16, 
17]. The recently introduced diacron reactive oxygen metab-
olites (d-ROMs) test (Diacron, Italy) can quantify the oxida-
tive stress status by measuring the levels of hydroperoxides 
of organic compounds (lipids, proteins, nucleic acids, etc.), 
and has been used as a simple clinical marker of oxidative 
stress [22-24].  However, earlier studies on exercise using 
the d-ROMs test have been only cross-sectionally conducted 
for players of specific sports [25-27].
In this context, although physical activity can reduce the 
respective markers of sdLDL and the oxidative stress status, 
more data are necessary to confirm the importance of physi-
cal activity with regard to both of these markers. Little clini-
cal information is available about the cross-linkage between 
sdLDL and oxidative stress from an intervention study on 
physical activity. We hypothesize that concomitant changes 
may be seen in sdLDL and oxidative stress, as assessed by 
the d-ROMs test, as a result of an increase in physical activ-
ity. Because their association is still unproven, the aim of 
the present study was to investigate the correlation between 
the mean LDL particle size and the d-ROMs levels among 
hyperlipidemic subjects during a physical activity interven-
tion period.
Methods
A 6-month intervention study was performed that included 
30 hyperlipidemic patients (12 male and 18 female, mean 
ages: 64 years). Hyperlipidemia was diagnosed according 
to the guidelines of the Japan Atherosclerosis Society (cir-
culating concentrations of LDL cholesterol (LDL-C) ≥ 3.64 
mmol/L, triglycerides (TG) ≥ 1.69 mmol/L) [28]. The inclu-
sion criteria was non-smokers, patients with regular exercise 
habits (structured exercise < 30 minutes, twice a week), and 
patients not taking any medications. The exclusion criteria 
Table 1. Measured Variables at the Pre- and Post-Intervention Examinations of Physical Activity in Hyperlip-
idemic Subjects
LDL: low-density lipoprotein, HDL: high-density lipoprotein, d-ROMs: diacron reactive oxygen metabolites. The data are 
shown as the means ± standard deviation or medians (interquartile range). A paired t-test was used to analyse the respective 
markers. Significance level: * P ≤ 0.05, ** P ≤ 0.01.
Variable Pre-intervention Post-intervention P-value
Age, years 64 ± 6 -
Male/female, number 12/18 -
Body mass index, kg/m2 23.5 ± 3.0 23.1 ± 2.7 0.01**
Systolic blood pressure, mmHg 139 ± 19 138 ± 21 0.79
Diastolic blood pressure, mmHg 77 ± 12 79 ± 15 0.32
Fasting plasma glucose, mmol/L 5.47 ± 0.82 5.37 ± 0.73 0.28
LDL-cholesterol, mmol/L 3.83 ± 0.50 3.44 ± 0.62 0.01**
Triglycerides, mmol/L 1.24 (0.99-1.53) 1.20 (0.82-1.41) 0.17
HDL-cholesterol, mmol/L 1.76 ± 0.40 1.78 ± 0.41 0.74
Mean LDL particle size, nm 26.9 ± 0.3 27.1 ± 0.4 0.01**
d-ROMs, U. Curr. 319 ± 77 290 ± 73 0.02**
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were individuals who were pregnant, had acute infections 
such as the common cold, were alcohol abusers, and those 
who had a history of diabetes, cardio/cerebrovascular, thy-
roid, collagen, severe kidney or liver diseases. The study was 
approved by the institutional ethics committee, and all sub-
jects gave their informed consent.
The  present  program,  which  focused  on  a  moderate 
physical activity increase, included monthly group sessions 
to promote physical activity, such as daily walking, and to 
instruct subjects on the appropriate methods by exercise spe-
cialists. In particular, the participants were educated on how 
to measure their heart rates during a walking period in their 
radial arterial pulses, and were recommended to walk at 60% 
of their maximal heart rate for at least 30 minutes.
In the pre- and post-intervention examinations, athero-
sclerotic risk variables were measured during an overnight 
fasted state. In addition to the body mass index (BMI), the 
systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) was measured in the right arm of each subject in the 
seated position after a 5-minute rest using a sphygmoma-
nometer. The serum lipid panels such as the LDL-C, TG and 
high-density  lipoprotein  cholesterol  (HDL-C)  and  plasma 
glucose levels were measured using enzymatic methods. The 
mean LDL particle size was measured with a high-resolu-
tion, nongradient polyacrylamide gel electrophoresis system 
(the Lipoprint system; Quantimetrix, Redondo Beach, CA, 
USA), which has been validated by using the gold standard 
method of nuclear magnetic resonance spectroscopy. Briefly, 
after serum samples (25 μL) were photopolymerized, the 
samples and loading gels were applied to gel tubes and then 
electrophoresed. The scanning system calculated the mean 
LDL particle size based on the fractionalized lipoproteins 
[29]. Furthermore, the d-ROMs values were measured us-
ing a kinetic spectrophotometric assay (the F.R.E.E system; 
Diacron,  Italy)  with  intra-  and  inter-assay  coefficients  of 
variation of 2.1% and 3.1%, respectively [22, 23]. Briefly, 
serum samples (25 μL) were mixed with a buffered solu-
tion, and a chromogenic substrate was added to the mixture. 
The mixture was then incubated in the thermostatic block 
of the system. The absorbance was recorded at 505 nm. The 
measurements are expressed in U. Carr., where 1 U. Carr. 
corresponds to 0.08 mg/dL H2O2.
The data are expressed as the means ± standard devia-
tions (SD) or the medians plus interquartile ranges. Paired 
Table 2. The Correlations of the Changes in the D-ROMs With Other Atherosclerotic Risk 
Variables, Including the Mean LDL Particle Size, in Hyperlipidemic Subjects
d-ROMs: diacron reactive oxygen metabolites, LDL: low-density lipoprotein, HDL: high-density lipo-
protein; r: simple correlation coefficient between the changes of the d-ROMs and  another variable, 
β: stepwise multiple regression coefficient of the change of the d-ROMs with  another variable after 
adjusting for all the listed variables. The triglycerides values were log-transformed for the analyses. 
Significance level: *P ≤ 0.05, **P ≤ 0.01.
Variables γ (P-value)  β (P-value)
Age, years -0.17 (0.38) -0.34 (0.05)*
Gender, male 0.05 (0.81) Not extracted
∆ Body mass index, kg/m2 0.40 (0.03)* Not extracted
∆ Systolic blood pressure, mmHg -0.34 (0.07) Not extracted
∆ Diastolic blood pressure, mmHg -0.17 (0.37) Not extracted
∆ Fasting plasma glucose, mmol/L 0.13 (0.50) Not extracted
∆ LDL-cholesterol, mmol/L 0.24 (0.21) Not extracted
∆ Tyiglecerides, mmol/L 0.38 (0.04)* Not extracted
∆ HDL-cholesterol, mmol/L -0.25 (0.19) Not extracted
∆ mean LDL particle size, nm -0.44 (0.02)* -0.55(0.01)**
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t-tests were used to compare the pre- and post-intervention 
levels of the respective variables. A Pearson’s correlation 
test for a simple univariate analysis and a stepwise multiple 
regression analysis adjusted for all of the listed variables 
were utilized to observe the correlation between the pre- and 
post-intervention changes of the d-ROMs levels and other 
atherosclerotic risk variables, including the mean LDL par-
ticle size. The values of TG were log-transformed for all the 
analyses because of their skewed distribution. A P-value ≤ 
0.05 was considered to be statistically significant.
 
Results
The clinical characteristics of the studied subjects are listed 
in Table 1. There was a significant reduction of the BMI, 
LDL-C and d-ROMs levels, while there was a significant 
increase of the mean LDL particle size, during the physical 
activity intervention period.
The correlations between the pre- and post-intervention 
changes in the d-ROMs and atherosclerotic risk variables are 
listed in Table 2. A simple univariate correlation test showed 
that the change in the d-ROMs levels was significantly and 
positively correlated with that of the BMI and TG, while the 
change in the d-ROMs was significantly and inversely cor-
related with that of the mean LDL particle size. A subsequent 
stepwise multiple regression analysis for the change in the 
d-ROMs levels revealed an independent, significant and in-
verse correlation between the change of the d-ROMs levels 
and the mean LDL particle size, although an independent, 
significant and inverse correlation of age with the change in 
the d-ROMs was also observed.
Discussion
  
The present study showed that there was an independent, 
significant and inverse correlation between the changes in 
the mean LDL particle size and the oxidative stress status, as 
evaluated by the d-ROMs test, during the physical activity 
intervention period in hyperlipidemic subjects. The present 
physical activity produced a significant increase in the mean 
LDL particle size and a significant reduction of the d-ROMs 
levels. While this was expected based on the findings of 
previous studies [12, 13, 18-21], these findings support the 
beneficial influence of physical activity on lipoprotein me-
tabolism and the oxidative stress status. On the other hand, 
the precise biological influence of regular physical activity 
on the CVD risk reduction remains to be determined [8-10], 
and the sdLDL and oxidative stress-related markers are as-
sociated with some issues that need to be resolved (i.e., inde-
pendency of the sdLDL-CVD association with other athero-
sclerotic risk factors [6] and the need for simple and useful 
markers to evaluate the oxidative stress status in the clinical 
setting [16, 17]). In addition, there have been few clinical 
intervention studies on physical activity available performed 
to  examine  the  cross-talk  between  sdLDL  and  oxidative 
stress. Therefore, it is valuable to note that our intervention 
study demonstrates that concomitant changes of sdLDL and 
oxidative stress can be associated with the reduction of the 
development of CVD, even when there is only a moderate 
increase in physical activity among hyperlipidemic subjects.
Small dense LDL can be formed in the in vivo environ-
ment due to an increase in the oxidative stress status, result-
ing from a sedentary lifestyle [6, 24]. An increase in physical 
activity might thus decrease the oxidative environment. In 
addition, sdLDL per se can enhance oxidative stress [2, 3, 
6]. Because of their low affinity for the LDL receptor, their 
prolonged half-life in the circulation and their low resistance 
to oxidative stress, sdLDL particles are more easily taken 
up in the arterial walls and display a high susceptibility to 
oxidation with their retention in the walls, leading to uptake 
by macrophages, and thereafter, foam cell formation [2, 3, 
6]. The atherosclerotic processes produce oxidative stress 
[30]. Physical activity might accelerate the clearance of cir-
culating sdLDL particles via increased lipase activities and 
attenuate the atherosclerotic processes in the arterial walls 
[11, 31]. More research is needed to clarify the biological 
mechanisms responsible for the correlation between sdLDL 
and oxidative stress.
There are some limitations associated with this study. 
Even though this was a prospective intervention study, a 
randomized-controlled design was not employed and there 
were no control subjects. The number of subjects was rela-
tively small, and the intervention period was relatively short. 
The intensity and amount of physical activity were not fully 
evaluated in this study. Therefore, these limitations will need 
to be addressed in future studies.
In summary, the present intervention study showed that 
there was an independent, significant and inverse correlation 
between the changes in the mean LDL particle size and the 
d-ROMs levels during a 6-month period of increased physi-
cal activity in hyperlipidemic subjects. The finding of a cor-
relation between the changes in both markers suggests that 
sdLDL  and  oxidative  stress  can  concomitantly  affect  the 
reduction of the CVD risk by even a moderate increase in 
physical activity in hyperlipidemic subjects. Further studies 
are required to confirm the observed relationship.
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